Luciana Borio

Luciana Borio is a Brazilian-American infectious disease physician and medical/public health administrator. 

She is a vice president at In-Q-Tel. She was Director for Medical and Biodefense Preparedness at the National Security Council, Acting Chief Scientist of the U.S. Food and Drug Administration (FDA), Assistant Commissioner for Counterterrorism Policy of the FDA, and Director of FDA's Office of Counterterrorism and Emerging Threats. 

She is known for her work advancing clinical trials, the development of medical countermeasures for health emergencies, and the public health responses to Ebola and Zika outbreaks.September 17, 2014, U.S. House of Representatives Committee on Foreign Affairs, Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations hearing entitled “Global Efforts to Fight Ebola”; October 16, 2014, U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Oversight and Investigations hearing entitled “Examining The U.S. Public Health Response to the Ebola Outbreak;” November 19, 2014, U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Health hearing entitled “Examining Medical Product Development in the Wake of the Ebola Epidemic;” February 26, 2015, U.S. Senate Committee on Health, Education, Labor and Pensions hearing entitled “Medical and Public Health Preparedness and Response: Are We Ready for Future Threats?” March 02, 2016, US House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations hearing entitled “Examining the U.S. Public Health Response to the Zika Virus.”

On November 9, 2020, U.S. president-elect Joe Biden named Borio to be one of the 13 members of his COVID-19 Advisory Board.

References

Category:Living people
Category:Naturalized citizens of the United States
Category:American physicians
Category:Brazilian physicians